Refine
Year of publication
Has Fulltext
- yes (123)
Is part of the Bibliography
- no (123)
Keywords
- LHC (7)
- ALICE (3)
- ALICE experiment (3)
- Hadron-Hadron Scattering (3)
- pp collisions (3)
- Beauty production (2)
- Breast cancer (2)
- Diagnostik (2)
- Früherkennung (2)
- Mammakarzinom (2)
- Nachsorge (2)
- Richtlinie (2)
- Single electrons (2)
- breast cancer (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- screening (2)
- 900 GeV (1)
- APP (1)
- Active middle ear implants (1)
- Atmospheric science (1)
- Auditory system (1)
- Australia (1)
- Bone conduction devices (1)
- Business strategy in drug development (1)
- C57BL/6J mice (1)
- C57BL/6N mice (1)
- CA1 (1)
- CABLE (1)
- COVID-19 (1)
- CVID (1)
- Cancer (1)
- Cancer stem cells (1)
- Cell biology (1)
- Charm physics (1)
- Chemical biology (1)
- Chocó rainforest (1)
- Climate change (1)
- Clinical variation (1)
- Cognitive impairment (1)
- Comparison with QCD (1)
- Consensus statement (1)
- Conservation biogeography (1)
- Deutsch (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital mammography (1)
- Drug discovery (1)
- Drug therapy (1)
- EBV (1)
- Ecuador (1)
- Elderly (1)
- EnKS 3D (1)
- European Society for Immunodeficiencies (ESID) (1)
- Femtoscopy (1)
- Frailty (1)
- GRACE (1)
- GRX1-roGFP2 (1)
- General practitioners (1)
- Genetic wildlife monitoring (1)
- German PID-NET registry (1)
- Glucose metabolism (1)
- HBT (1)
- Hadron production (1)
- Hair sampling (1)
- Health policy (1)
- Heavy Ions (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hypertension (1)
- IgG substitution therapy (1)
- Inclusive spectra (1)
- Insulin secretion (1)
- Intensity interferometry (1)
- Jets (1)
- KCGS (1)
- LTER (1)
- Long‐term ecosystem research (1)
- Lure sticks (1)
- MACE (1)
- Mid-rapidity (1)
- Mitochondrial shuttles (1)
- Mixed hearing loss (1)
- Morphologie (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- Noninvasive genetic sampling (1)
- North China Plain (1)
- Nuclear modification factor (1)
- Oldest-old (1)
- PCR-GLOBWB (1)
- PID prevalence (1)
- PYTHIA (1)
- Pancreatic islet (1)
- Parkinson disease (1)
- Pb–Pb (1)
- Population-based screening (1)
- Proton–proton (1)
- RT-qPCR (1)
- Recall rate (1)
- Redox-sensitive GFP (1)
- Rehabilitation (1)
- Relativistic heavy ion physics (1)
- Research infrastructure (1)
- SARS-CoV-2 (1)
- Satzanalyse (1)
- Semantik (1)
- Single muons (1)
- Site networks (1)
- Stimulus-secretion coupling (1)
- Surgery (1)
- Syntax (1)
- Technical data (1)
- Transverse momentum (1)
- W3 (1)
- WGHM (1)
- aboveground biomass (1)
- atherosclerosis (1)
- biodiversity (1)
- cardiovascular disease (1)
- chemogenomic set (1)
- chronosequence (1)
- data assimilation (1)
- dentate gyrus (1)
- diabetic macular edema (1)
- diclofenac (1)
- drug discovery (1)
- druggable genome (1)
- epigenetics (1)
- fluocinolone acetonide (1)
- groundwater storage (1)
- hemodialysis (1)
- immunostaining (1)
- in situ hybridization (1)
- kidney disease (1)
- kinase inhibitor (1)
- laser microdissection (1)
- meta-analysis (1)
- miRNA (1)
- microdosing (1)
- neutralizing antibodies (1)
- next-generation sequencing (1)
- oral enzyme combination (1)
- osteoarthritis (1)
- phenotypic screening (1)
- primary immunodeficiency (PID) (1)
- protein kinase (1)
- randomized controlled trial (1)
- reassembly (1)
- registry for primary immunodeficiency (1)
- resilience (1)
- resistance (1)
- small molecules (1)
- spectra (1)
- spike protein (1)
- trees (1)
- understudied kinase (1)
- variants of concern (1)
- western blotting (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (78)
- Frankfurt Institute for Advanced Studies (FIAS) (65)
- Informatik (65)
- Medizin (28)
- Biodiversität und Klima Forschungszentrum (BiK-F) (5)
- Senckenbergische Naturforschende Gesellschaft (5)
- Biowissenschaften (4)
- Biochemie und Chemie (3)
- Exzellenzcluster Makromolekulare Komplexe (3)
- Institut für Ökologie, Evolution und Diversität (3)
The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification
(2019)
We describe the assembly and annotation of a chemogenomic set of protein kinase inhibitors as an open science resource for studying kinase biology. The set only includes inhibitors that show potent kinase inhibition and a narrow spectrum of activity when screened across a large panel of kinase biochemical assays. Currently, the set contains 187 inhibitors that cover 215 human kinases. The kinase chemogenomic set (KCGS) is the most highly annotated set of selective kinase inhibitors available to researchers for use in cell-based screens.
Serial quantification of BCR–ABL1 mRNA is an important therapeutic indicator in chronic myeloid leukaemia, but there is a substantial variation in results reported by different laboratories. To improve comparability, an internationally accepted plasmid certified reference material (CRM) was developed according to ISO Guide 34:2009. Fragments of BCR–ABL1 (e14a2 mRNA fusion), BCR and GUSB transcripts were amplified and cloned into pUC18 to yield plasmid pIRMM0099. Six different linearised plasmid solutions were produced with the following copy number concentrations, assigned by digital PCR, and expanded uncertainties: 1.08±0.13 × 106, 1.08±0.11 × 105, 1.03±0.10 × 104, 1.02±0.09 × 103, 1.04±0.10 × 102 and 10.0±1.5 copies/μl. The certification of the material for the number of specific DNA fragments per plasmid, copy number concentration of the plasmid solutions and the assessment of inter-unit heterogeneity and stability were performed according to ISO Guide 35:2006. Two suitability studies performed by 63 BCR–ABL1 testing laboratories demonstrated that this set of 6 plasmid CRMs can help to standardise a number of measured transcripts of e14a2 BCR–ABL1 and three control genes (ABL1, BCR and GUSB). The set of six plasmid CRMs is distributed worldwide by the Institute for Reference Materials and Measurements (Belgium) and its authorised distributors (https://ec.europa.eu/jrc/en/reference-materials/catalogue/; CRM code ERM-AD623a-f).
Combinatorial CRISPR-Cas screens have advanced the mapping of genetic interactions, but their experimental scale limits the number of targetable gene combinations. Here, we describe 3Cs multiplexing, a rapid and scalable method to generate highly diverse and uniformly distributed combinatorial CRISPR libraries. We demonstrate that the library distribution skew is the critical determinant of its required screening coverage. By circumventing iterative cloning of PCR-amplified oligonucleotides, 3Cs multiplexing facilitates the generation of combinatorial CRISPR libraries with low distribution skews. We show that combinatorial 3Cs libraries can be screened with minimal coverages, reducing associated efforts and costs at least 10-fold. We apply a 3Cs multiplexing library targeting 12,736 autophagy gene combinations with 247,032 paired gRNAs in viability and reporter-based enrichment screens. In the viability screen, we identify, among others, the synthetic lethal WDR45B-PIK3R4 and the proliferation-enhancing ATG7-KEAP1 genetic interactions. In the reporter-based screen, we identify over 1,570 essential genetic interactions for autophagy flux, including interactions among paralogous genes, namely ATG2A-ATG2B, GABARAP-MAP1LC3B and GABARAP-GABARAPL2. However, we only observe few genetic interactions within paralogous gene families of more than two members, indicating functional compensation between them. This work establishes 3Cs multiplexing as a platform for genetic interaction screens at scale.